Singular Genomics Systems, Inc. Common Stock
OMIC
OMIC was delisted on the 20th of February, 2025.
66 hedge funds and large institutions have $43.8M invested in Singular Genomics Systems, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 16 increasing their positions, 21 reducing their positions, and 18 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
18% less funds holding
Funds holding: 80 → 66 (-14)
24% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 21
41% less capital invested
Capital invested by funds: $74.8M → $43.8M (-$30.9M)
72% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$253K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$125K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$120K |
| 4 |
HighTower Advisors
Chicago,
Illinois
|
+$81.5K |
| 5 |
JP Morgan Chase
New York
|
+$76.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$1.65M |
| 2 |
OMC
Oasis Management Company
Grand Cayman,
Cayman Islands
|
-$446K |
| 3 |
Coatue Management
New York
|
-$352K |
| 4 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$341K |
| 5 |
BlackRock
New York
|
-$160K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PMEF
76
Point72 Middle East FZE
Dubai,
United Arab Emirates
| – | -$3.74K | -62 | Closed |
|
77
Citigroup
New York
| – | -$2.56K | -43 | Closed |
|
78
Simplex Trading
Chicago,
Illinois
| – | -$1.9K | -31 | -91% |
|
|
TWA
79
TCI Wealth Advisors
Tucson,
Arizona
| – | -$949 | -16 | Closed |
|
|
NHT
80
New Hampshire Trust
Concord,
New Hampshire
| – | -$832 | -14 | Closed |
|
|
GWS
81
Glassman Wealth Services
Vienna,
Virginia
| – | -$406 | -7 | Closed |
|
|
CS
82
Credit Suisse
Zurich,
Switzerland
| – | -$4 | – | – |
|
OMIC Hedge Fund Activity: Q1 2023 in Review
66 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Singular Genomics Systems, Inc. Common Stock (OMIC) for Q1 2023, worth a combined $43.8M — down 41% from $74.8M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of OMIC and 5 opened new positions — a net loss of 13 holders — while 21 trimmed existing stakes and 16 added.
The largest buyer was GSA Capital Partners, adding an estimated $253K. The largest seller was Goldman Sachs, cutting an estimated $1.65M.
- 66 institutional investors held Singular Genomics Systems, Inc. Common Stock (OMIC) as of Q1 2023, down from 80 in Q4 2022.
- Funds reported $43.8M of Singular Genomics Systems, Inc. Common Stock stock for Q1 2023, down 41% quarter-over-quarter.
- 5 funds opened new Singular Genomics Systems, Inc. Common Stock positions in Q1 2023 and 18 closed out, a net change of -13 holders.
- The largest Singular Genomics Systems, Inc. Common Stock buyer in Q1 2023 was GSA Capital Partners, an estimated $253K added.
- The largest Singular Genomics Systems, Inc. Common Stock seller in Q1 2023 was Goldman Sachs, an estimated $1.65M sold.
Based on aggregated 13F filings for Q1 2023.